Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

External medicine composition for treating traumata and skin and external diseases

A composition and drug technology, applied in the field of pharmacy, can solve the problems of high production cost, unfavorable cell survival, no economic benefits, etc., and achieve the effects of significant curative effect and wide therapeutic range.

Inactive Publication Date: 2016-02-17
GUANGDONG PHARMA UNIV
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The wounds of diabetic patients are difficult to heal and are very susceptible to infection. There are many reasons for this. The main reasons are: ①Diabetic patients have abnormal sugar utilization, which cannot effectively convert glucose into protein and other substances to promote wound tissue healing; ②Diabetic patients have hyperglycemia in tissues Lead to tissue cell hyperosmosis, which is not conducive to cell survival; ③ high blood sugar can lead to immune decline, weaken the immune ability of the incision, and easily cause infection
At present, there are few related drugs for the wound treatment of diabetic patients.
[0004] Most of the existing traditional Chinese medicine compound external medicines for treating skin trauma have many medicinal flavors, up to more than 20 flavors, the production cost is high, the price is higher than some western medicines, and they are not economical and practical.
Some are single medicines, and the curative effect is worse than that of compound medicines

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • External medicine composition for treating traumata and skin and external diseases
  • External medicine composition for treating traumata and skin and external diseases
  • External medicine composition for treating traumata and skin and external diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] An external pharmaceutical composition for treating wounds and sores, which consists of: 45 parts of honeysuckle, 20 parts of angelica, 20 parts of black plum, 20 parts of Galla chinensis, 20 parts of Kozi, 20 parts of rhubarb, and 20 parts of Cortex Phellodendri, calculated in parts by mass .

Embodiment 2

[0022] An external pharmaceutical composition for treating wounds and sores, which consists of: 50 parts of honeysuckle, 25 parts of angelica, 25 parts of black plum, 25 parts of Galla chinensis, 25 parts of Kozi, 25 parts of rhubarb, and 25 parts of Cortex Phellodendri, calculated in parts by mass .

Embodiment 3

[0024] An external pharmaceutical composition for treating wounds and sores, which consists of: 55 parts of honeysuckle, 30 parts of angelica, 30 parts of dark plum, 30 parts of Galla gall, 30 parts of Kozi, 30 parts of rhubarb, and 30 parts of Cortex Phellodendri, in parts by mass .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an external medicine composition for treating traumata and skin and external diseases. The external medicine composition is mainly prepared from seven medicines including honeysuckle, angelica sinensis, smoked plum, gallnuts, terminalia chebula retz, rheum officinale and golden cypress, and all of the monarch, minister, assistant and guide medicines are combined, so as to achieve the effects of promoting blood circulation, diminishing swelling, detoxifying and promoting granulation. The selected medicine are fewer but better, according to the principle that both symptoms and root causes can be treated when diseases are treated, fewer fine traditional Chinese medicines are selected, and the requirements of economy, greenness and the like are satisfied. The medicine composition can be used for curing the traumata, the skin and external diseases, diabetic wounds and skin and external diseases which are difficult to heal and can be used for treating hordeolum, paronychia, acne and dental ulcer, and the wounds almost have no scar.

Description

technical field [0001] The invention belongs to the field of pharmacy, and in particular relates to an external pharmaceutical composition for treating trauma, sores, diabetic trauma and sores. Background technique [0002] At present, most domestic medicines for treating skin trauma and ulcers are compound Chinese medicines, and Chinese medicines are effective in treating chronic ulcers. Traditional Chinese medicine for treating ulcers is mainly divided into promoting qi and activating blood, drying dampness and concentrating, and sour and astringent for closing the mouth. [0003] The number of people with diabetes is increasing year by year, and tends to be younger. According to the World Health Organization, it will increase to 300 million people by 2025. Diabetes is harmful, mainly because of its serious complications and high mortality. Data show that diabetic foot amputation is one of the most expensive complications of treatment. The wounds of diabetic patients ar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/756A61P17/02A61P3/10A61P27/02A61P31/04A61P17/00A61P17/10A61P1/02A61K35/64
Inventor 姬生国王东黄柳芳赵红宁刘喜乐曹庆玺
Owner GUANGDONG PHARMA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products